[HTML][HTML] Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load

CL Swan, V Dushimiyimana, P Ndishimye… - Iscience, 2023 - cell.com
Summary SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-
19 (coronavirus disease 2019) poses a greater health risk to immunocompromized …

[HTML][HTML] SARS-CoV-2 humoral immunity in people living with HIV-1

BM Motsoeneng, JN Bhiman, SI Richardson… - Trends in …, 2024 - cell.com
The effect of COVID-19 on the high number of immunocompromised people living with HIV-1
(PLWH), particularly in Africa, remains a critical concern. Here, we identify key areas that still …

[PDF][PDF] Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave

J Snyman, SH Hwa, R Krause, D Muema… - Clinical Infectious …, 2021 - pure.mpg.de
Background. There is limited understanding of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pathogenesis in African populations with a high burden of …

[HTML][HTML] Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens

H Nantambi, J Sembera, V Ankunda, I Ssali… - Frontiers in …, 2023 - frontiersin.org
Introduction We investigated whether prior SARS-CoV-2-specific IFN-γ and antibody
responses in Ugandan COVID-19 pre-pandemic specimens aligned to this population's low …

[HTML][HTML] SARS-CoV-2 and HIV-1: Should HIV-1-infected individuals in sub-saharan Africa Be considered a priority group for the COVID-19 vaccines?

WL Mandala, MKP Liu - Frontiers in Immunology, 2021 - frontiersin.org
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity
and mortality compared to the other prevailing coronaviruses. Although initially most African …

Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)

CT Costiniuk, J Singer, T Lee, Y Galipeau… - AIDS, 2023 - journals.lww.com
Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people living with HIV (PLWH). Here, we compare COVID-19 vaccine-induced …

[HTML][HTML] Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

CT Costiniuk, J Singer, T Lee, Y Galipeau… - AIDS, 2023 - journals.lww.com
Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people with HIV (PWH). Here, we compare coronavirus disease 2019 (COVID …

[HTML][HTML] Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals

AL Batchi-Bouyou, JC Djontu, JC Vouvoungui… - BMC Infectious …, 2022 - Springer
Background Assessing immune responses after vaccination is part of the evaluation
package of vaccine effectiveness in the real world. Regarding SARS-CoV-2, neutralizing …

Similar antibody responses against severe acute respiratory syndrome coronavirus 2 in individuals living without and with human immunodeficiency virus on …

J Snyman, SH Hwa, R Krause, D Muema… - Clinical Infectious …, 2022 - academic.oup.com
Background There is limited understanding of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pathogenesis in African populations with a high burden of …

Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 Beta variant

SH Hwa, J Snyman, M Bernstein… - The Journal of …, 2023 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may
be associated with worse clinical outcomes in people with human immunodeficiency virus …